Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2979771rdf:typepubmed:Citationlld:pubmed
pubmed-article:2979771lifeskim:mentionsumls-concept:C0007102lld:lifeskim
pubmed-article:2979771lifeskim:mentionsumls-concept:C0008810lld:lifeskim
pubmed-article:2979771lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:2979771lifeskim:mentionsumls-concept:C2348767lld:lifeskim
pubmed-article:2979771lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:2979771pubmed:issue2lld:pubmed
pubmed-article:2979771pubmed:dateCreated1992-3-12lld:pubmed
pubmed-article:2979771pubmed:abstractTextMice bearing the murine colon carcinomas Colon 38 or Colon 26 were treated with 5-fluorouracil (5 FU) (60 or 100 mg/kg, respectively) weekly for 4 weeks at 08.30 hr or at 18.30 hr. The antitumor effect of treatment at 08.30 hr was significantly better for both types of tumors, but most pronounced for Colon 38. Toxicity was evaluated after administration of 60 mg 5 FU/kg. No thrombocytopenia was observed. Leucopenia was observed after treatment at 18.30 hr. It is concluded that the therapeutic efficacy of 5 FU against murine colon cancer is higher when 5 FU is administered at 08.30 hr.lld:pubmed
pubmed-article:2979771pubmed:languageenglld:pubmed
pubmed-article:2979771pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2979771pubmed:citationSubsetIMlld:pubmed
pubmed-article:2979771pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2979771pubmed:statusMEDLINElld:pubmed
pubmed-article:2979771pubmed:issn0258-851Xlld:pubmed
pubmed-article:2979771pubmed:authorpubmed-author:PinedoH MHMlld:pubmed
pubmed-article:2979771pubmed:authorpubmed-author:PetersG JGJlld:pubmed
pubmed-article:2979771pubmed:authorpubmed-author:LankelmaJJlld:pubmed
pubmed-article:2979771pubmed:authorpubmed-author:Van DijkJJlld:pubmed
pubmed-article:2979771pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:2979771pubmed:authorpubmed-author:NadalJ CJClld:pubmed
pubmed-article:2979771pubmed:issnTypePrintlld:pubmed
pubmed-article:2979771pubmed:volume1lld:pubmed
pubmed-article:2979771pubmed:ownerNLMlld:pubmed
pubmed-article:2979771pubmed:authorsCompleteYlld:pubmed
pubmed-article:2979771pubmed:pagination113-7lld:pubmed
pubmed-article:2979771pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2979771pubmed:meshHeadingpubmed-meshheading:2979771-...lld:pubmed
pubmed-article:2979771pubmed:meshHeadingpubmed-meshheading:2979771-...lld:pubmed
pubmed-article:2979771pubmed:meshHeadingpubmed-meshheading:2979771-...lld:pubmed
pubmed-article:2979771pubmed:meshHeadingpubmed-meshheading:2979771-...lld:pubmed
pubmed-article:2979771pubmed:meshHeadingpubmed-meshheading:2979771-...lld:pubmed
pubmed-article:2979771pubmed:meshHeadingpubmed-meshheading:2979771-...lld:pubmed
pubmed-article:2979771pubmed:meshHeadingpubmed-meshheading:2979771-...lld:pubmed
pubmed-article:2979771pubmed:meshHeadingpubmed-meshheading:2979771-...lld:pubmed
pubmed-article:2979771pubmed:meshHeadingpubmed-meshheading:2979771-...lld:pubmed
pubmed-article:2979771pubmed:meshHeadingpubmed-meshheading:2979771-...lld:pubmed
pubmed-article:2979771pubmed:meshHeadingpubmed-meshheading:2979771-...lld:pubmed
pubmed-article:2979771pubmed:articleTitleDiurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer.lld:pubmed
pubmed-article:2979771pubmed:affiliationDepartment of Oncology, Free University Hospital, Amsterdam, The Netherlands.lld:pubmed
pubmed-article:2979771pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2979771pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2979771lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2979771lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2979771lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2979771lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2979771lld:pubmed